Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

por Koinis, F, Agelaki, S, Karavassilis, V, Kentepozidis, N, Samantas, E, Peroukidis, S, Katsaounis, P, Hartabilas, E, Varthalitis, I I, Messaritakis, I, Fountzilas, G, Georgoulias, V, Kotsakis, A
Publicado 2017

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

por Mountzios, G., Samantas, E., Senghas, K., Zervas, E., Krisam, J., Samitas, K., Bozorgmehr, F., Kuon, J., Agelaki, S., Baka, S., Athanasiadis, I., Gaissmaier, L., Elshiaty, M., Daniello, L., Christopoulou, A., Pentheroudakis, G., Lianos, E., Linardou, H., Kriegsmann, K., Kosmidis, P., El Shafie, R., Kriegsmann, M., Psyrri, A., Andreadis, C., Fountzilas, E., Heussel, C.-P., Herth, F.J., Winter, H., Emmanouilides, C., Oikonomopoulos, G., Meister, M., Muley, T., Bischoff, H., Saridaki, Z., Razis, E., Perdikouri, E.-I., Stenzinger, A., Boukovinas, I., Reck, M., Syrigos, K., Thomas, M., Christopoulos, P.
Publicado 2021